Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP.

Yuxi GongHaitao YanYefan YangBoya ZhaiZhendong HuangZhi-Hong Zhang

Published in: Pharmacogenomics and personalized medicine (2023)

The novel nomogram incorporating the three independent risk factors (BCL2 expression, CD10 expression and LDH level) provided a valuable tool for predicting DLBCL recurrence.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
poor prognosis
risk factors
lymph node metastasis
free survival
binding protein
squamous cell carcinoma
high density